Fulminant emphysematous hepatitis with massive intravascular haemolysis due to Clostridium perfringens infection

Queralt Herms1,2, Natalia Jiménez3,2, Anna Merino4

  • 1Liver ICU, Liver Unit, Hospital Clínic Barcelona, Barcelona, Spain queralthermsrubio@gmail.com.

BMJ Case Reports
|July 30, 2026
PubMed

Insights

Clostridium perfringens caused a rare, fatal case of emphysematous hepatitis and severe hemolysis in an elderly patient. Early recognition and treatment of this Clostridium perfringens infection are crucial for survival.

Area of Science:

  • Infectious Diseases
  • Hepatology
  • Critical Care Medicine

Background:

  • Clostridium perfringens is an anaerobic bacterium known for potent exotoxin production and fulminant infections.
  • Liver abscesses caused by C. perfringens, particularly with hemolysis, are documented but rare.
  • Emphysematous hepatitis, characterized by gas in hepatic lesions, indicates severe infection.

Purpose of the Study:

  • To report an exceedingly rare case of fulminant Clostridium perfringens infection presenting as emphysematous hepatitis with severe hemolysis.
  • To emphasize the clinical presentation, diagnostic challenges, and outcomes of this catastrophic condition.

Main Methods:

  • Case report of an elderly male patient with multiple comorbidities.
  • Clinical presentation including acute abdominal pain, vomiting, and rapid deterioration.
  • Diagnostic workup involving CT scan revealing gas-containing hepatic lesions and blood cultures confirming C. perfringens.

Main Results:

  • The patient exhibited rapid clinical decline with altered mental status, progressive anemia, metabolic acidosis, and multiorgan dysfunction.
  • CT scan findings were consistent with emphysematous hepatitis.
  • Despite prompt antimicrobial therapy and supportive care, the patient succumbed to progressive multiorgan failure within 96 hours.

Conclusions:

  • This case underscores the rarity of combined fulminant hemolysis and emphysematous hepatitis due to C. perfringens.
  • Highlights the critical need for prompt recognition, immediate antimicrobial intervention, and source control in such severe presentations.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...